The prognosis of EZH2-positive breast carcinoma is worse than that of EZH2-negative cases, as the 5-year survival rate was 81 and 91 % in patients with EZH2-positive or -negative breast carcinoma, respectively [21]. The gene discussed is EZH2; the disease is breast carcinoma.